GT Biopharma
GTBP
GTBP
17 hedge funds and large institutions have $349K invested in GT Biopharma in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
88% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 17
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$7.27K | |
| 2 | +$2.37K | |
| 3 | +$271 | |
| 4 |
BNP Paribas Financial Markets
Paris,
France
|
+$27 |
Top Sellers
| 1 | -$69.8K | |
| 2 | -$29K | |
| 3 | -$25.2K | |
| 4 |
Bank of New York Mellon
New York
|
-$24.3K |
| 5 |
State Street
Boston,
Massachusetts
|
-$20.4K |